Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.8%

165 terminated/withdrawn out of 2840 trials

Success Rate

92.6%

+6.1% vs industry average

Late-Stage Pipeline

8%

234 trials in Phase 3/4

Results Transparency

42%

871 of 2051 completed trials have results

Key Signals

332 recruiting871 with results93 terminated72 withdrawn

Enrollment Performance

Analytics

N/A
1236(48.2%)
Phase 2
561(21.9%)
Phase 1
441(17.2%)
Phase 4
120(4.7%)
Phase 3
114(4.4%)
Early Phase 1
90(3.5%)
2562Total
N/A(1236)
Phase 2(561)
Phase 1(441)
Phase 4(120)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2840)

Showing 20 of 2840 trials
NCT06860607Phase 1Recruiting

Environment and Alcohol: A Pilot Study

Role: lead

NCT05881304Not ApplicableCompleted

Switching Individuals in Treatment for Opioid Use Disorder Who Smoke Cigarettes to the SREC

Role: collaborator

NCT06676059Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Role: lead

NCT04903028Not ApplicableRecruiting

RTMS Targets Neural Circuits for Smoking Cessation

Role: collaborator

NCT07215221Not ApplicableNot Yet Recruiting

Implementation of TBI-RECOVER in Substance Use Treatment

Role: collaborator

NCT05807139Phase 1Recruiting

Spironolactone in Alcohol Use Disorder (SAUD)

Role: lead

NCT04701437Not ApplicableActive Not Recruiting

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Role: collaborator

NCT06561828Early Phase 1Recruiting

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

Role: lead

NCT07002554Phase 2Enrolling By Invitation

Bright Light Therapy for Depressed Geriatric Inpatients

Role: collaborator

NCT07202039Not ApplicableNot Yet Recruiting

Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine

Role: collaborator

NCT06868914Phase 1Not Yet Recruiting

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Role: lead

NCT07438041Not ApplicableNot Yet Recruiting

Linking Youth to Pre-Exposure Prophylaxis (PrEP) Services

Role: collaborator

NCT06577454Not ApplicableSuspended

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Role: lead

NCT06995885Enrolling By Invitation

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Role: lead

NCT07099092Early Phase 1Not Yet Recruiting

Causal Mechanisms of Odor-Guided Behavior in Humans

Role: lead

NCT06323824Phase 4Recruiting

Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.

Role: collaborator

NCT05485012Phase 1Completed

Reinforcing Effects of Marijuana and Opioids

Role: collaborator

NCT07485335Phase 4Not Yet Recruiting

A Bundled Intervention to End Opioid Overdoses

Role: collaborator

NCT05039554Not ApplicableRecruiting

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

Role: collaborator

NCT03670316Phase 4Completed

Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care

Role: collaborator